Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger protein 4 pseudogene (ENSG00000227934) is a nonfunctional stretch of DNA in the human genome that resembles the RNF4 gene but does not encode a functional protein product[1][2]. Pseudogenes typically arise from duplication or retrotransposition events but accumulate disabling mutations such as premature stop codons or frame shifts, rendering them unable to produce functional proteins[2]. They are often classified as "junk DNA," although some may be transcribed at low levels, rarely giving rise to regulatory RNA, but there is no evidence of functional or therapeutic roles for the ring finger protein 4 pseudogene[2]. This pseudogene should not be confused with the functional RNF4 gene, which encodes a RING finger E3 ubiquitin ligase with established roles in transcription regulation and disease[6]. If your intention was to reference a therapeutic target, the correct entity would be the Ring finger protein 4 (RNF4), a distinct and functional protein-coding gene[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger protein 4 pseudogene.